BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38669827)

  • 1. Potential role of Vitamin D in immune response in patients with viral hepatitis.
    Gerhards C; Teufel A; Gerigk M; French M; Antoni C; Ebert M; Neumaier M; Evliyaoglu O
    Nutrition; 2024 Aug; 124():112447. PubMed ID: 38669827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Study of Correlation Between Serum Vitamin D
    Ko WS; Yang YP; Shen FP; Wu MC; Shih CJ; Lu MC; Yan YH; Chiou YL
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase.
    Ko WS; Shen FP; Shih CJ; Chiou YL
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
    Li CZ; Hu JJ; Xue JY; Yin W; Liu YY; Fan WH; Xu H; Liang XS
    World J Gastroenterol; 2014 Jul; 20(28):9486-96. PubMed ID: 25071343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte subsets in peripheral blood and liver tissue of patients with chronic hepatitis B and C.
    Dimitropoulou D; Karakantza M; Tsamandas AC; Mouzaki A; Theodorou G; Gogos CA
    In Vivo; 2011; 25(5):833-40. PubMed ID: 21753143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Serum Vitamin D Levels on Cellular Immunity and Antiviral Effects in Chronic Hepatitis B Patients.
    He LJ; Zhang HP; Li HJ; Wang J; Chang DD
    Clin Lab; 2016 Oct; 62(10):1933-1939. PubMed ID: 28164523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.
    Wang L; Qiu J; Yu L; Hu X; Zhao P; Jiang Y
    J Transl Med; 2014 Sep; 12():251. PubMed ID: 25199644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
    Le Bert N; Salimzadeh L; Gill US; Dutertre CA; Facchetti F; Tan A; Hung M; Novikov N; Lampertico P; Fletcher SP; Kennedy PTF; Bertoletti A
    J Hepatol; 2020 Jan; 72(1):34-44. PubMed ID: 31348999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
    Vyas AK; Sharma BC; Sarin SK; Trehanpati N
    Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL13-mediated recruitment of intrahepatic CXCR5
    Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
    J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
    García-López M; Lens S; Pallett LJ; Testoni B; Rodríguez-Tajes S; Mariño Z; Bartres C; García-Pras E; Leonel T; Perpiñán E; Lozano JJ; Rodríguez-Frías F; Koutsoudakis G; Zoulim F; Maini MK; Forns X; Pérez-Del-Pulgar S
    J Hepatol; 2021 May; 74(5):1064-1074. PubMed ID: 33278456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
    J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.